All problems
For UK pharmaceutical and life sciences leaders
NICE approval secured, but trust-level uptake is far below your launch projections
NICE approval creates permission to operate in the NHS. It does not create demand. The gap between national guidance and local clinical adoption is where most pharmaceutical launches stall, and where structured field force and medical affairs strategy is required.
Two minutes. Solva follows up with a specific adoption strategy assessment.